{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:27:40Z","timestamp":1780478860814,"version":"3.54.1"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.canlet.2021.02.024","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T17:51:21Z","timestamp":1614966681000},"page":"35-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["3D human liver organoids: An in vitro platform to investigate HBV infection, replication and liver tumorigenesis"],"prefix":"10.1016","volume":"506","author":[{"given":"Shringar","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4765-6600","authenticated-orcid":false,"given":"Tanvir","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokameh","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2021.02.024_bib1","doi-asserted-by":"crossref","first-page":"a021345","DOI":"10.1101\/cshperspect.a021345","article-title":"Viral hepatitis: past and future of HBV and HDV","volume":"5","author":"Thomas","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.canlet.2021.02.024_bib2","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2021.02.024_bib3","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0140-6736(15)61116-3","article-title":"Estimating the global prevalence of hepatitis B","volume":"386","author":"MacLachlan","year":"2015","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.canlet.2021.02.024_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/liv.13656","article-title":"Towards HBV curative therapies","volume":"38","author":"Schinazi","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.canlet.2021.02.024_bib5","doi-asserted-by":"crossref","first-page":"11630","DOI":"10.3748\/wjg.v20.i33.11630","article-title":"Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis","volume":"20","author":"Tarocchi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2021.02.024_bib6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ng.2291","article-title":"Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators","volume":"44","author":"Fujimoto","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2021.02.024_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma","volume":"44","author":"Sung","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2021.02.024_bib8","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.3748\/wjg.v20.i30.10238","article-title":"Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma","volume":"20","author":"Ali","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2021.02.024_bib9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/ng.3126","article-title":"Trans-ancestry mutational landscape of hepatocellular carcinoma genomes","volume":"46","author":"Totoki","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2021.02.024_bib10","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3390\/ijms20061358","article-title":"Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review","volume":"20","author":"Kanda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2021.02.024_bib11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1186\/s12885-019-5916-6","article-title":"HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models","volume":"19","author":"Torresi","year":"2019","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2021.02.024_bib12","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1128\/jvi.69.10.6158-6169.1995","article-title":"High-level hepatitis B virus replication in transgenic mice","volume":"69","author":"Guidotti","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2021.02.024_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00281-012-0335-7","article-title":"Experimental models and therapeutic approaches for HBV","volume":"35","author":"Dandri","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.canlet.2021.02.024_bib14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.510290228","article-title":"The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents","volume":"29","author":"Ilan","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2021.02.024_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcmgh.2017.11.005","article-title":"Engineered livers for infectious diseases","volume":"5","author":"Gural","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2021.02.024_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.aau7307","article-title":"Long-term functional maintenance of primary human hepatocytes in vitro","volume":"364","author":"Xiang","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.canlet.2021.02.024_bib17","doi-asserted-by":"crossref","first-page":"45698","DOI":"10.1038\/srep45698","article-title":"Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection","volume":"7","author":"Sakurai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2021.02.024_bib18","doi-asserted-by":"crossref","first-page":"29358","DOI":"10.1038\/srep29358","article-title":"Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus","volume":"6","author":"Kaneko","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2021.02.024_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature11826","article-title":"In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration","volume":"494","author":"Huch","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2021.02.024_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","article-title":"Long-term culture of genome-stable bipotent stem cells from adult human liver","volume":"160","author":"Huch","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2021.02.024_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ebiom.2018.08.014","article-title":"Recapitulation of hepatitis B virus-host interactions in liver organoids from human induced pluripotent stem cells","volume":"35","author":"Nie","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2021.02.024_bib22","series-title":"Human Liver Organoids; a Patient-Derived Primary Model for HBV Infection and Related Hepatocellular Carcinoma","first-page":"568147","author":"Crignis","year":"2020"},{"key":"10.1016\/j.canlet.2021.02.024_bib23","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1242\/dev.118570","article-title":"Modeling mouse and human development using organoid cultures","volume":"142","author":"Huch","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.canlet.2021.02.024_bib24","doi-asserted-by":"crossref","first-page":"1247125","DOI":"10.1126\/science.1247125","article-title":"Organogenesis in a dish: modeling development and disease using organoid technologies","volume":"345","author":"Lancaster","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.canlet.2021.02.024_bib25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2021.02.024_bib26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature12271","article-title":"Vascularized and functional human liver from an iPSC-derived organ bud transplant","volume":"499","author":"Takebe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2021.02.024_bib27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nprot.2014.020","article-title":"Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant","volume":"9","author":"Takebe","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2021.02.024_bib28","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.celrep.2017.11.005","article-title":"Massive and reproducible production of liver buds entirely from human pluripotent stem cells","volume":"21","author":"Takebe","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2021.02.024_bib29","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.1038\/s41598-019-45514-3","article-title":"Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with Endothelial Cells","volume":"9","author":"Pettinato","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2021.02.024_bib30","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41422-019-0242-8","article-title":"Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2021.02.024_bib31","first-page":"2","article-title":"Human hepatic organoids for the analysis of human genetic diseases","author":"Guan","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2021.02.024_bib32","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jhep.2018.12.028","article-title":"Generation of hepatobiliary organoids from human induced pluripotent stem cells","volume":"70","author":"Wu","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2021.02.024_bib33","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","article-title":"Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids","volume":"30","author":"Ouchi","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2021.02.024_bib34","article-title":"Production of human pluripotent stem cell-derived hepatic cell lineages and liver organoids: current status and potential applications","volume":"7","author":"Cotovio","year":"2020","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.canlet.2021.02.024_bib35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.stem.2016.06.017","article-title":"Molecular obstacles to clinical translation of iPSCs","volume":"19","author":"Tapia","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2021.02.024_bib36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/ncb2239","article-title":"Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells","volume":"13","author":"Ohi","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2021.02.024_bib37","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature19768","article-title":"Tissue-specific mutation accumulation in human adult stem cells during life","volume":"538","author":"Blokzijl","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2021.02.024_bib38","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.celrep.2018.07.001","article-title":"Organoid models of human liver cancers derived from tumor needle biopsies","volume":"24","author":"Nuciforo","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2021.02.024_bib39","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0092-8674(80)90443-2","article-title":"Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand","volume":"21","author":"Gerlich","year":"1980","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2021.02.024_bib40","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1128\/jvi.67.12.7414-7422.1993","article-title":"Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor","volume":"67","author":"Klingm\u00fcller","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2021.02.024_bib41","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.canlet.2021.02.024_bib42","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1073\/pnas.1811064116","article-title":"Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization","volume":"116","author":"Iwamoto","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2021.02.024_bib43","first-page":"9","article-title":"Hepatitis B virus entry into cells","author":"Herrscher","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2021.02.024_bib44","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2021.02.024_bib45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/jmbi.2000.4481","article-title":"Structural organization of the hepatitis B virus minichromosome","volume":"307","author":"Bock","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.canlet.2021.02.024_bib46","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jhep.2016.01.027","article-title":"Overview of hepatitis B viral replication and genetic variability","volume":"64","author":"Tong","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2021.02.024_bib47","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1128\/jvi.63.12.5451-5454.1989","article-title":"Internal entry of ribosomes and ribosomal scanning involved in hepatitis B virus P gene expression","volume":"63","author":"Jean-Jean","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2021.02.024_bib48","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1128\/JVI.78.21.11751-11757.2004","article-title":"Translation of duck hepatitis B virus reverse transcriptase by ribosomal shunting","volume":"78","author":"Sen","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2021.02.024_bib49","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1128\/jvi.67.6.3254-3263.1993","article-title":"An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation","volume":"67","author":"Pollack","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2021.02.024_bib50","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1128\/jvi.61.3.904-911.1987","article-title":"Replication strategy of human hepatitis B virus","volume":"61","author":"Will","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2021.02.024_bib51","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nri.2016.69","article-title":"Immune responses and immunopathology in acute and chronic viral hepatitis","volume":"16","author":"Shin","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2021.02.024_bib52","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2021.02.024_bib53","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0140-6736(15)61116-3","article-title":"Estimating the global prevalence of hepatitis B","volume":"386","author":"MacLachlan","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2021.02.024_bib54","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2021.02.024_bib55","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1101\/gr.133926.111","article-title":"The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients","volume":"22","author":"Jiang","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.canlet.2021.02.024_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s15010-019-01345-y","article-title":"Epidemiological and etiological variations in hepatocellular carcinoma","volume":"48","author":"Sagnelli","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.canlet.2021.02.024_bib57","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2021.02.024_bib58","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ng.2391","article-title":"Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma","volume":"44","author":"Huang","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2021.02.024_bib59","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2174\/1389202915666141114213833","article-title":"Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinoma","volume":"15","author":"Ji","year":"2014","journal-title":"Curr. Genom."},{"key":"10.1016\/j.canlet.2021.02.024_bib60","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrgastro.2016.37","article-title":"Experimental models of hepatitis B and C - new insights and progress","volume":"13","author":"Thomas","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2021.02.024_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2015.09.016","article-title":"Activation of signal transduction pathways during hepatic oncogenesis","volume":"370","author":"Chung","year":"2016","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2021.02.024_bib62","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/cr.2008.30","article-title":"The IkappaB kinase - a bridge between inflammation and cancer","volume":"18","author":"Karin","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2021.02.024_bib63","article-title":"Hepatitis B virus X protein and hepatocarcinogenesis","volume":"17","author":"Liu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2021.02.024_bib64","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","article-title":"Mechanisms of HBV-induced hepatocellular carcinoma","volume":"64","author":"Levrero","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2021.02.024_bib65","first-page":"12","article-title":"The hepatitis B virus pre-core protein p22 activates Wnt signaling","author":"Tran","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2021.02.024_bib66","doi-asserted-by":"crossref","first-page":"11215","DOI":"10.1073\/pnas.92.24.11215","article-title":"Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls","volume":"92","author":"Benn","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2021.02.024_bib67","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1038\/emm.2016.177","article-title":"Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma","volume":"49","author":"Zhang","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.canlet.2021.02.024_bib68","doi-asserted-by":"crossref","first-page":"14707","DOI":"10.1073\/pnas.94.26.14707","article-title":"Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis","volume":"94","author":"Elmore","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2021.02.024_bib69","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.4254\/wjh.v8.i25.1061","article-title":"Inhibition of apoptosis by oncogenic hepatitis B virus X protein: implications for the treatment of hepatocellular carcinoma","volume":"8","author":"Chao","year":"2016","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.canlet.2021.02.024_bib70","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2021.02.024_bib71","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM199510263331702","article-title":"Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B","volume":"333","author":"McKenzie","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2021.02.024_bib72","doi-asserted-by":"crossref","first-page":"16700","DOI":"10.1074\/jbc.M513825200","article-title":"Identification of the mitochondrial targeting signal of the human equilibrative nucleoside transporter 1 (hENT1) implications for interspecies differences IN mitochondrial toxicity OF fialuridine","volume":"281","author":"Lee","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2021.02.024_bib73","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/hep.22506","article-title":"Molecular targeted therapies in hepatocellular carcinoma","volume":"48","author":"Llovet","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2021.02.024_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174153","article-title":"Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines","volume":"12","author":"Haga","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.canlet.2021.02.024_bib75","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.virusres.2009.09.012","article-title":"Dysregulation of hepatocyte cell cycle and cell viability by hepatitis B virus","volume":"147","author":"Chin","year":"2010","journal-title":"Virus Res."},{"key":"10.1016\/j.canlet.2021.02.024_bib76","doi-asserted-by":"crossref","first-page":"26580","DOI":"10.1073\/pnas.1911273116","article-title":"Pancreatic cancer organoids recapitulate disease and allow personalized drug screening","volume":"116","author":"Driehuis","year":"2019","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.canlet.2021.02.024_bib77","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2021.02.024_bib78","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A living biobank of breast cancer organoids captures disease heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2021.02.024_bib79","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1750","article-title":"Idiosyncratic drug hepatotoxicity","volume":"4","author":"Kaplowitz","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2021.02.024_bib80","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.virusres.2017.12.007","article-title":"Current concepts on immunopathogenesis of hepatitis B virus infection","volume":"245","author":"Peeridogaheh","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.canlet.2021.02.024_bib81","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3389\/fimmu.2018.01561","article-title":"Hepatitis B virus adaptation to the CD8+ T cell response: consequences for host and pathogen","volume":"9","author":"Lumley","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2021.02.024_bib82","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000456584","article-title":"Overcoming CD8+ T-cell exhaustion in viral hepatitis: lessons from the mouse model and clinical perspectives","volume":"35","author":"Wieland","year":"2017","journal-title":"Dig. Dis."},{"key":"10.1016\/j.canlet.2021.02.024_bib83","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2021.02.024_bib84","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2021.02.024_bib85","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/eji.201141852","article-title":"Blockade of Tim-3 signaling restores the virus-specific CD8(+) T-cell response in patients with chronic hepatitis B","volume":"42","author":"Wu","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.canlet.2021.02.024_bib86","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.24249","article-title":"Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection","volume":"53","author":"Schurich","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2021.02.024_bib87","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","article-title":"Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B","volume":"138","author":"Fisicaro","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2021.02.024_bib88","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"Rehermann","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2021.02.024_bib89","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1172\/JCI83339","article-title":"In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection","volume":"126","author":"Zhang","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2021.02.024_bib90","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/j.gastro.2018.01.034","article-title":"Hepatitis B virus does not interfere with innate immune responses in the human liver","volume":"154","author":"Suslov","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2021.02.024_bib91","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.aaw7894","article-title":"Organoids-on-a-chip","volume":"364","author":"Park","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.canlet.2021.02.024_bib92","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/mi10030165","article-title":"Engineering microfluidic organoid-on-a-chip platforms","volume":"10","author":"Yu","year":"2019","journal-title":"Micromachines"},{"key":"10.1016\/j.canlet.2021.02.024_bib93","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1039\/C8LC00869H","article-title":"In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system","volume":"18","author":"Wang","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.canlet.2021.02.024_bib94","doi-asserted-by":"crossref","first-page":"1801954","DOI":"10.1002\/adfm.201801954","article-title":"Vascularized liver organoids generated using induced hepatic tissue and dynamic liver-specific microenvironment as a drug testing platform","volume":"28","author":"Jin","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.canlet.2021.02.024_bib95","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biomaterials.2015.08.043","article-title":"A microfluidically perfused three dimensional human liver model","volume":"71","author":"Rennert","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2021.02.024_bib96","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1039\/C6LC00598E","article-title":"Engineering a perfusable 3D human liver platform from iPS cells","volume":"16","author":"Schepers","year":"2016","journal-title":"Lab Chip"},{"key":"10.1016\/j.canlet.2021.02.024_bib97","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/toxsci\/kfw169","article-title":"Modeling compound-induced fibrogenesis in vitro using three-dimensional bioprinted human liver tissues","volume":"154","author":"Norona","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.canlet.2021.02.024_bib98","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/8\/1\/014101","article-title":"A liver-on-a-chip platform with bioprinted hepatic spheroids","volume":"8","author":"Bhise","year":"2016","journal-title":"Biofabrication"},{"key":"10.1016\/j.canlet.2021.02.024_bib99","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ab4a30","article-title":"3D bioprinting of liver spheroids derived from human induced pluripotent stem cells sustain liver function and viability in vitro","volume":"12","author":"Goulart","year":"2019","journal-title":"Biofabrication"},{"key":"10.1016\/j.canlet.2021.02.024_bib100","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41467-018-02969-8","article-title":"3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection","volume":"9","author":"Ortega-Prieto","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2021.02.024_bib101","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJM199312163292508","article-title":"Acute liver failure","volume":"329","author":"Lee","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2021.02.024_bib102","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2021.02.024_bib103","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.68","article-title":"Targeting hepatitis B virus with CRISPR\/Cas9","volume":"3","author":"Seeger","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.canlet.2021.02.024_bib104","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-pathmechdis-012419-032611","article-title":"Human organoids: tools for understanding biology and treating diseases","volume":"15","author":"Schutgens","year":"2020","journal-title":"Annu. Rev. Pathol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521001038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521001038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:54:53Z","timestamp":1759593293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383521001038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":104,"alternative-id":["S0304383521001038"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2021.02.024","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3D human liver organoids: An in vitro platform to investigate HBV infection, replication and liver tumorigenesis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2021.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}